Mylan Surges After Quickly Settling With DoJ Over EpiPen Medicaid Rebates |
| October 08, 2016 | October 2016 Bond Updates |
|
Mylan will pay $465 million to settle with the Department of Justice over its classification of EpiPen in Medicaid rebate programs. |
| View more at: http://www.forbes.com/sites/antoinegara/2016/10/07/mylan-surges-after-quickly-settling-with-doj-over-epipen-medicaid-rebates/ |
| Related News |
|